vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and VIRTUS INVESTMENT PARTNERS, INC. (VRTS). Click either name above to swap in a different company.
COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $199.5M, roughly 1.0× VIRTUS INVESTMENT PARTNERS, INC.). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs 3.6%, a 4.7% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs -4.1%). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs -5.7%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
VIRTUS INVESTMENT PARTNERS, INC.VRTSEarnings & Financial Report
Virtus Investment Partners, Inc. is an American company which operates as a multi-manager asset management business, comprising a number of individual affiliated managers, each having its own investment process and brand, and the services of unaffiliated sub advisers.
COLL vs VRTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $199.5M |
| Net Profit | $17.0M | $7.1M |
| Gross Margin | 62.5% | — |
| Operating Margin | 29.6% | 7.7% |
| Net Margin | 8.3% | 3.6% |
| Revenue YoY | 12.9% | -4.1% |
| Net Profit YoY | 35.3% | -78.1% |
| EPS (diluted) | $0.48 | $1.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $199.5M | ||
| Q4 25 | $205.4M | $208.0M | ||
| Q3 25 | $209.4M | $216.4M | ||
| Q2 25 | $188.0M | $210.5M | ||
| Q1 25 | $177.8M | $217.9M | ||
| Q4 24 | $181.9M | $233.5M | ||
| Q3 24 | $159.3M | $227.0M | ||
| Q2 24 | $145.3M | $224.4M |
| Q1 26 | — | $7.1M | ||
| Q4 25 | $17.0M | $33.9M | ||
| Q3 25 | $31.5M | $31.3M | ||
| Q2 25 | $12.0M | $42.7M | ||
| Q1 25 | $2.4M | $28.1M | ||
| Q4 24 | $12.5M | $39.5M | ||
| Q3 24 | $9.3M | $49.1M | ||
| Q2 24 | $19.6M | $26.0M |
| Q1 26 | — | — | ||
| Q4 25 | 62.5% | — | ||
| Q3 25 | 61.7% | — | ||
| Q2 25 | 57.7% | — | ||
| Q1 25 | 54.8% | — | ||
| Q4 24 | 54.0% | — | ||
| Q3 24 | 60.8% | — | ||
| Q2 24 | 62.5% | — |
| Q1 26 | — | 7.7% | ||
| Q4 25 | 29.6% | 19.1% | ||
| Q3 25 | 29.7% | 21.7% | ||
| Q2 25 | 18.7% | 21.5% | ||
| Q1 25 | 12.2% | 16.8% | ||
| Q4 24 | 20.9% | 21.7% | ||
| Q3 24 | 21.9% | 24.3% | ||
| Q2 24 | 32.7% | 19.7% |
| Q1 26 | — | 3.6% | ||
| Q4 25 | 8.3% | 16.3% | ||
| Q3 25 | 15.0% | 14.5% | ||
| Q2 25 | 6.4% | 20.3% | ||
| Q1 25 | 1.4% | 12.9% | ||
| Q4 24 | 6.9% | 16.9% | ||
| Q3 24 | 5.9% | 21.6% | ||
| Q2 24 | 13.5% | 11.6% |
| Q1 26 | — | $1.05 | ||
| Q4 25 | $0.48 | $5.15 | ||
| Q3 25 | $0.84 | $4.65 | ||
| Q2 25 | $0.34 | $6.12 | ||
| Q1 25 | $0.07 | $4.05 | ||
| Q4 24 | $0.36 | $4.65 | ||
| Q3 24 | $0.27 | $5.71 | ||
| Q2 24 | $0.52 | $2.43 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $136.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $301.7M | $93.6B |
| Total Assets | $1.7B | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $136.6M | ||
| Q4 25 | $386.7M | — | ||
| Q3 25 | $285.9M | — | ||
| Q2 25 | $222.2M | — | ||
| Q1 25 | $197.8M | — | ||
| Q4 24 | $162.8M | — | ||
| Q3 24 | $120.0M | — | ||
| Q2 24 | $271.6M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $390.0M | ||
| Q3 25 | — | $390.6M | ||
| Q2 25 | — | $231.3M | ||
| Q1 25 | — | $231.7M | ||
| Q4 24 | — | $232.1M | ||
| Q3 24 | — | $237.5M | ||
| Q2 24 | — | $247.6M |
| Q1 26 | — | $93.6B | ||
| Q4 25 | $301.7M | $934.0M | ||
| Q3 25 | $274.8M | $918.7M | ||
| Q2 25 | $232.2M | $896.4M | ||
| Q1 25 | $234.4M | $893.7M | ||
| Q4 24 | $228.8M | $897.5M | ||
| Q3 24 | $234.3M | $889.0M | ||
| Q2 24 | $216.6M | $868.7M |
| Q1 26 | — | — | ||
| Q4 25 | $1.7B | $4.3B | ||
| Q3 25 | $1.6B | $3.9B | ||
| Q2 25 | $1.6B | $3.7B | ||
| Q1 25 | $1.6B | $3.7B | ||
| Q4 24 | $1.7B | $4.0B | ||
| Q3 24 | $1.6B | $3.6B | ||
| Q2 24 | $1.1B | $3.6B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.42× | ||
| Q3 25 | — | 0.43× | ||
| Q2 25 | — | 0.26× | ||
| Q1 25 | — | 0.26× | ||
| Q4 24 | — | 0.26× | ||
| Q3 24 | — | 0.27× | ||
| Q2 24 | — | 0.29× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | — |
| Free Cash FlowOCF − Capex | $122.4M | — |
| FCF MarginFCF / Revenue | 59.6% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | 7.25× | — |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $123.0M | $-67.2M | ||
| Q3 25 | $78.4M | $108.3M | ||
| Q2 25 | $72.4M | $75.8M | ||
| Q1 25 | $55.4M | $-3.8M | ||
| Q4 24 | $84.6M | $1.8M | ||
| Q3 24 | $-9.0M | $69.1M | ||
| Q2 24 | $67.4M | $70.0M |
| Q1 26 | — | — | ||
| Q4 25 | $122.4M | $-74.1M | ||
| Q3 25 | $78.3M | $106.9M | ||
| Q2 25 | $72.4M | $74.2M | ||
| Q1 25 | $54.6M | $-6.8M | ||
| Q4 24 | $84.1M | $-3.8M | ||
| Q3 24 | $-9.2M | $68.7M | ||
| Q2 24 | $67.1M | $68.6M |
| Q1 26 | — | — | ||
| Q4 25 | 59.6% | -35.6% | ||
| Q3 25 | 37.4% | 49.4% | ||
| Q2 25 | 38.5% | 35.2% | ||
| Q1 25 | 30.7% | -3.1% | ||
| Q4 24 | 46.2% | -1.6% | ||
| Q3 24 | -5.8% | 30.3% | ||
| Q2 24 | 46.2% | 30.6% |
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 3.3% | ||
| Q3 25 | 0.1% | 0.7% | ||
| Q2 25 | 0.0% | 0.7% | ||
| Q1 25 | 0.4% | 1.4% | ||
| Q4 24 | 0.3% | 2.4% | ||
| Q3 24 | 0.2% | 0.2% | ||
| Q2 24 | 0.2% | 0.6% |
| Q1 26 | — | — | ||
| Q4 25 | 7.25× | -1.99× | ||
| Q3 25 | 2.49× | 3.45× | ||
| Q2 25 | 6.05× | 1.77× | ||
| Q1 25 | 22.92× | -0.13× | ||
| Q4 24 | 6.75× | 0.04× | ||
| Q3 24 | -0.96× | 1.41× | ||
| Q2 24 | 3.44× | 2.69× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COLL
Segment breakdown not available.
VRTS
| Investment management fees | $169.1M | 85% |
| Administration and shareholder service fees | $17.3M | 9% |
| Distribution and service fees | $11.6M | 6% |
